Outpatient Antimicrobial Program Shortens Follow-Up Time for Bone and Joint Infection Patients
A nurse practitioner-led complex outpatient antimicrobial therapy (COpAT) program reduced the average time to post-discharge follow-up from 20.1 to 9.7 days for patients with bone and joint infections. Despite this improvement in care coordination, the intervention did not significantly lower rates of 30-day readmissions or emergency department visits. The findings highlight challenges in translating streamlined follow-up into reduced healthcare utilization.
A nurse practitioner-led complex outpatient antimicrobial therapy (COpAT) program at an unnamed institution significantly reduced the average time to post-discharge follow-up for patients with bone and joint infections—from 20.1 days to 9.7 days—between 2023 and 2026. This improvement in care coordination was achieved through structured outpatient management, likely involving early scheduling of visits, enhanced communication between providers, and standardized protocols. Despite this progress in timely follow-up, the intervention did not result in a statistically significant reduction in 30-day readmission rates or emergency department visits. The findings underscore a persistent gap between improved process metrics and actual reductions in healthcare utilization, suggesting that faster follow-up alone may not be sufficient to prevent complications or rehospitalization. The study is part of broader efforts to refine antimicrobial stewardship and outpatient management for serious infections, particularly those caused by resistant organisms like Staphylococcus aureus.
The background includes prior guidelines from the Infectious Diseases Society of America (IDSA) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), which have increasingly emphasized outpatient treatment options for selected patients with serious infections. The 2026 consensus statements, particularly Statements 6 and 7 on Staphylococcus aureus bacteremia, provide updated recomm
The success of outpatient antimicrobial programs like COpAT could reshape how healthcare systems manage complex infections, potentially reducing inpatient stays and lowering costs. However, the lack of impact on readmissions suggests that care coordination alone is insufficient—especially for vulnerable populations facing barriers like transportation, housing instability, or limited access to follow-up providers. This may prompt health systems to expand support services beyond clinical monitoring, such as telehealth check-ins or mobile nursing visits. A comparable earlier case is the shift toward outpatient parenteral antibiotic therapy (OPAT) in the 2010s, which initially showed promise but faced similar challenges in reducing readmissions due to unmet social needs. The current findings may accelerate interest in integrated care models that bundle medical and non-medical support. Moving forward, health systems could pilot bundled payment models tied to both follow-up timeliness and pa